Objective:

To announce the first commercial cases of the FLIGHT procedure, a new non-incisional glaucoma surgery in Europe.

Approach:

Key Findings:

• FLIGHT is a minimally invasive, image-guided alternative to traditional glaucoma surgery.
• The procedure aims to restore aqueous outflow and lower intraocular pressure in patients with open-angle glaucoma.
• The technology allows for precision treatment without the need to open the eye, addressing an unmet need for incision-free options.

Interpretation:

The FLIGHT procedure represents a potential shift in glaucoma intervention, allowing for earlier treatment in the disease continuum.

Limitations:

• The FLIGHT procedure is currently only commercialized in Europe and remains investigational in the United States.

Conclusion:

The launch of FLIGHT represents an important step for ViaLase in glaucoma care.

Sources:

• BusinessWire
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.